Company / EPS (Basic)
Biofrontera Inc. EPS (Basic) History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Basic)
-$3.22
FY2025
5-year range
-$13.02 / -$0.61
FY2022-FY2025
Trend
+75.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Declined from $-0.61 to $-3.22 over the past 2 years.
Based on SEC 10-K filings.
-3.22 in FY2025.
Declined from $-0.61 to $-3.22 over the past 2 years.
EPS (Basic) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, eps (basic) increased 75.3% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -0.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Basic)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$3.22 | +75.3% |
| FY2024 | -$13.02 | -2034.4% |
| FY2023 | -$0.61 | +85.7% |
| FY2022 | -$4.28 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026